Device
Litramine
Litramine is a medical device with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 5 completed trials
Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
20%(1 trials)
Phase Distribution
Ph not_applicable
2
40%
Ph phase_3
1
20%
Ph phase_4
2
40%
Phase Distribution
0
Early Stage
0
Mid Stage
3
Late Stage
Phase Distribution5 total trials
Phase 3Large-scale testing
1(20.0%)
Phase 4Post-market surveillance
2(40.0%)
N/ANon-phased studies
2(40.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
5 of 5 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(5)
Detailed Status
Completed5
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 31 (20.0%)
Phase 42 (40.0%)
N/A2 (40.0%)
Trials by Status
completed5100%
Recent Activity
0 active trials
Showing 5 of 5
completednot_applicable
Efficacy and Safety of Litramine in 1 Year Weight Loss Study
NCT03227276
completednot_applicable
Litramine for Weight Loss
NCT02488356
completedphase_4
Litramine in Weight Maintenance
NCT01505387
completedphase_4
Effect of Litramine on Fat Excretion
NCT01590667
completedphase_3
Safety and Efficacy of Litramine in Overweight and Obese Subjects
NCT01233349
Clinical Trials (5)
Showing 5 of 5 trials
NCT03227276Not Applicable
Efficacy and Safety of Litramine in 1 Year Weight Loss Study
NCT02488356Not Applicable
Litramine for Weight Loss
NCT01505387Phase 4
Litramine in Weight Maintenance
NCT01590667Phase 4
Effect of Litramine on Fat Excretion
NCT01233349Phase 3
Safety and Efficacy of Litramine in Overweight and Obese Subjects
All 5 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 5